UnitedHealth Group Incorporated $UNH Shares Acquired by MLG Wealth Management DBA Pine Grove Financial Group

MLG Wealth Management DBA Pine Grove Financial Group grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 21.6% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 7,231 shares of the healthcare conglomerate’s stock after purchasing an additional 1,284 shares during the period. MLG Wealth Management DBA Pine Grove Financial Group’s holdings in UnitedHealth Group were worth $3,006,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the company. Sarver Vrooman Wealth Advisors acquired a new stake in UnitedHealth Group during the fourth quarter valued at $25,000. Aberdeen Wealth Management LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $31,000. Nalls Sherbakoff Group LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $27,000. Lifetime Wealth Management P.C. purchased a new position in UnitedHealth Group during the fourth quarter worth approximately $29,000. Finally, Wilkerson Advisory Group LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $396.79 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The firm has a market capitalization of $356.15 billion, a PE ratio of 25.53, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The business has a 50 day simple moving average of $411.20 and a 200-day simple moving average of $365.42.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. During the same period in the prior year, the business earned $4.08 EPS. The firm’s quarterly revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s payout ratio is currently 59.72%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on UNH shares. Truist Financial lifted their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Barclays lifted their target price on shares of UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a research report on Monday, July 20th. HSBC upped their price target on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a research report on Monday, July 6th. Oppenheimer boosted their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research note on Friday, July 17th. Finally, JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $466.00 to $516.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $456.56.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.